cerrar
Tagged with R&D

How 3D Bioprinting is Revolutionizing Personalized Medicine
With the US FDA approval of a 3D bioprinted drug in 2016, the floodgates have been opened for a new wave of innovative, personalized and customizable…

Tattoo Sensor Technology: The Future of Maltese Innovation?
UMANA T1 – a patient monitoring ecosystem that uses tattoo sensor technology to measure and record heart rate and other physiological parameters –…

José Manuel Rigueiro – General Manager, Actelion Spain
Jose Manuel Rigueiro, general manager of the Spanish affiliate of Actelion, discusses the lack of trust between health authorities and the industry…

Interview: Nelson Pires – General Manager, Jaba Recordati…
Nelson Pires provides an insightful update on Portugual’s pharmaceutical market evolution as well as Jaba Recordati’s ambitious Portuguese…

Interview: Chris Molloy – Chief Executive, Medicines…
Chris Molloy, chief executive of the Medicines Discovery Catapult (MDC), discusses its role within the UK as a center for applied medical R&D and…

Robotics: Changing the Face of Drug Discovery
While the automotive and electronics industries, among others, have been relatively fast in adopting robotics, pharma has been lagging behind.…

Top Pharma R&D Spenders in Europe Ranking
The top spenders on pharma R&D in Europe for 2015 were Switzerland - which spent over EUR 6.5 billion - followed by Germany - which spent EUR 6.2…

Interview: Jose Escribano – Founder, ALGENEX, Spain
Jose Escribano, founder of Spanish biotech success story ALGENEX, discusses the company’s focus on using insects in its research, difficulties in…

China’s Greater Bay Area: Spearheading Innovation
Guangdong province and neighbouring Hong Kong have long been fundamental to China’s metamorphosis into an economic superpower. Notable as one of the…

Interview: Shine Liu Xiancheng – CEO, Lifotronic, China
Shine Liu Xiancheng, CEO and founder of Lifotronic, discusses the rise of the medtech manufacturer over its ten years of existence, its commitment to…

Interview: Paulo Teixeira – General Manager, Pfizer…
Paulo Teixeira shines a light on Pfizer’s promising pipeline for 2018, the market access environment in Portugal and the clinical trial landscape.…

Hugo Fry – Managing Director, Sanofi UK
Hugo Fry, managing director of Sanofi UK, details the impact of the company’s changing structure, the continued relevance of the UK market despite…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here